Search research articles
Contact Us
Filters
Showing results (61-70 of 87) with videos related to
Page
of 9
Sort By:
Biochemistry
|
September 11, 2024
DNA Replication across α-l-(3'-2')-Threofuranosyl Nucleotides Mediated by Human DNA Polymerase η
Rachana Tomar, Pratibha P Ghodke, Amritraj Patra, et al.
Histopathology
|
February 22, 2018
Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy - results from the MRC OE02 oesophageal cancer trial
Nasser Davarzani, Gordon G A Hutchins, Nicholas P West, et al.
Journal of Gastrointestinal Cancer
|
August 17, 2010
A 67-year-old woman with BRCA 1 mutation associated with pancreatic adenocarcinoma
Maeve Lowery, Manish A Shah, Elizabeth Smyth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2017
Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy
Elizabeth Smyth, Shenli Zhang, David Cunningham, et al.
Endocrine-Related Cancer
|
June 18, 2024
Insights on epidemiology, morbidity and mortality of Cushing's disease in Northern Ireland
Paul Benjamin Loughrey, Brian Herron, Stephen Cooke, et al.
British Journal of Cancer
|
August 24, 2021
Highlights from ASCO-GI 2021 from EORTC Gastrointestinal tract cancer group
Thibaud Koessler, Maria Alsina, Dirk Arnold, et al.
Clinical Colorectal Cancer
|
May 31, 2022
Highlights from the 2022 ASCO gastrointestinal cancer symposium: An overview by the EORTC gastrointestinal tract cancer group
Francesco Sclafani, Elisa Fontana, Lucjan Wyrwicz, et al.
The Lancet. Oncology
|
June 17, 2023
Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study
Eric Van Cutsem, Maria di Bartolomeo, Elizabeth Smyth, et al.
Journal of Surgical Oncology
|
August 17, 2021
The role of surgery after prolonged primary chemotherapy for advanced oesophageal adenocarcinoma
Mohamed S Aboul-Enein, William Knight, Wahyu Wulaningsih, et al.
Gastroenterology
|
February 8, 2020
Identification of Subtypes of Barrett's Esophagus and Esophageal Adenocarcinoma Based on DNA Methylation Profiles and Integration of Transcriptome and Genome Data
SriGanesh Jammula, Annalise C Katz-Summercorn, Xiaodun Li, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 87) with videos related to
Sort By:
Page
of 9
Biochemistry
|
September 11, 2024
DNA Replication across α-l-(3'-2')-Threofuranosyl Nucleotides Mediated by Human DNA Polymerase η
Rachana Tomar, Pratibha P Ghodke, Amritraj Patra, et al.
Histopathology
|
February 22, 2018
Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy - results from the MRC OE02 oesophageal cancer trial
Nasser Davarzani, Gordon G A Hutchins, Nicholas P West, et al.
Journal of Gastrointestinal Cancer
|
August 17, 2010
A 67-year-old woman with BRCA 1 mutation associated with pancreatic adenocarcinoma
Maeve Lowery, Manish A Shah, Elizabeth Smyth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2017
Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy
Elizabeth Smyth, Shenli Zhang, David Cunningham, et al.
Endocrine-Related Cancer
|
June 18, 2024
Insights on epidemiology, morbidity and mortality of Cushing's disease in Northern Ireland
Paul Benjamin Loughrey, Brian Herron, Stephen Cooke, et al.
British Journal of Cancer
|
August 24, 2021
Highlights from ASCO-GI 2021 from EORTC Gastrointestinal tract cancer group
Thibaud Koessler, Maria Alsina, Dirk Arnold, et al.
Clinical Colorectal Cancer
|
May 31, 2022
Highlights from the 2022 ASCO gastrointestinal cancer symposium: An overview by the EORTC gastrointestinal tract cancer group
Francesco Sclafani, Elisa Fontana, Lucjan Wyrwicz, et al.
The Lancet. Oncology
|
June 17, 2023
Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study
Eric Van Cutsem, Maria di Bartolomeo, Elizabeth Smyth, et al.
Journal of Surgical Oncology
|
August 17, 2021
The role of surgery after prolonged primary chemotherapy for advanced oesophageal adenocarcinoma
Mohamed S Aboul-Enein, William Knight, Wahyu Wulaningsih, et al.
Gastroenterology
|
February 8, 2020
Identification of Subtypes of Barrett's Esophagus and Esophageal Adenocarcinoma Based on DNA Methylation Profiles and Integration of Transcriptome and Genome Data
SriGanesh Jammula, Annalise C Katz-Summercorn, Xiaodun Li, et al.
Page
of 9